Tumor necrosis factor alpha (TNF alpha) localizes to the epidermis when injected in vivo, but its role in the skin has heretofore not been evaluated. As a first approach to assessing the role of TNF alpha in the skin, we evaluated the binding and biological effects of TNF alpha on human neonatal foreskin keratinocytes maintained in culture. We found that TNF alpha at 0.3-1.0 nM inhibited proliferation of keratinocytes in a reversible fashion as demonstrated by a reduction in total DNA content and clonal growth. The antiproliferative effects were most marked when TNF alpha was added in the preconfluent stages of cell growth. Accompanying this antiproliferative effect was a stimulation by TNF alpha of differentiation of keratinocytes as indicated by the stimulation of cornified envelope formation. Keratinocytes specifically bound TNF alpha, reaching maximal binding in 2 h at 340C or 8 h at 4VC. Much of the apparent binding at 340C was due to internalization of the TNF alpha. At 4VC the rate of internalization was much less. Confluent keratinocytes showed a single class of high-affinity receptors with 1,250 receptors/cell and a Kd of 0.28 nM. These data suggest a role for TNF alpha in the growth and differentiation of the epidermis.
Introduction
The epidermis undergoes a continuous process of growth and differentiation as cells progress from the basal proliferating layer to the stratum corneum which is eventually sloughed off. A similar process is observed in vitro with cultured epidermal cells or keratinocytes (1) (2) (3) , making these cells a useful model for the study of growth and differentiation. Cytokines such as epidermal growth factor (4), transforming growth factors (5) , and IFN (6) , as well as retinoids (7), vitamin D metabolites (8, 9) , calcium (10, 1 1), and cAMP (12) are all known to alter the growth and differentiation of keratinocytes. Tumor necrosis factor alpha (TNF alpha),' a cytokine secreted by stimulated macrophages, is known to bind to and regulate the growth and function of a number of cells in vitro (13) (14) (15) (16) (17) (18) . A highly significant amount (30%) of TNF alpha localizes to the epidermis after intravenous administration (19) , raising the possibility that the keratinocyte is also a target for TNF alpha binding and action. The results to be described in this report indicate that TNF alpha inhibits proliferation but stimulates differentiation of keratinocytes at concentrations equivalent to the Kd of the keratinocyte receptors for TNF alpha.
Methods
Cell culture. Human keratinocytes were isolated from human newborn foreskins by treatment with 0.25% trypsin overnight at 4VC. This procedure is selective for keratinocytes since fibroblasts require collagenase for isolation. The cells were plated onto a feeder monolayer of mitomycin C-treated 3T3 cells in 6-well multiwell plates and grown in DME containing 5% FCS, epidermal growth factor, cholera toxin, hydrocortisone, and antibiotics (20) . A Effect ofTNF alpha on differentiation ofkeratinocytes. The formation of cornified envelopes was quantitated using the method of King et al. (23) . The cells in triplicate wells were exposed to 2 MACi of [35S]-methionine/ml media for 48 h. The washed cells were then dissolved in 2 ml of2% SDS, 20 mM DTT solution and the amount ofradioactivity incorporated into the cross-linked, detergent-insoluble, cornified envelope was quantitated by liquid scintillation spectroscopy after collecting the envelopes on 10-Mm pore size filters. These assays were performed in triplicate and each data point represented the mean of triplicate values from separate culture dishes.
Statistical analysis for the effects of TNF alpha were performed by analysis of variance using the appropriate programs in Systat (Systat, Inc., Evanston, IL).
Binding ofTNF alpha to keratinocytes. Recombinant human TNF alpha, kindly supplied by Dr. Michael Shepard of Genentech, Inc., South San Francisco, CA, was iodinated by the iodogen method and purified as previously described (24) . This method resulted in a fully biologically active form of '25I-TNF alpha that remained stable for at least 4 wk. 125ITT4F alpha had a specific activity of 800 Ci/mmol of protein.
To determine the extent of TNF alpha binding to keratinocytes, 400,000 cpm of '251I-TNF alpha was incubated with confluent cultures of keratinocytes at 4VC, 240C, and 340C for up to 20 h. The nonspecific binding was determined by the '25I1-TNF alpha binding to keratinocytes in the presence of 100 nM nonlabeled TNF alpha. The medium was removed, the cells were rinsed three times with the binding buffer, and the cell-bound radioactivity was solubilized in 1% SDS and quantitated in a gamma counter. Nonspecific binding, determined in presence of excess (100 nM) TNF alpha, was subtracted from the total binding to determine the specific binding. To determine the degree to which the bound TNF alpha was internalized, the cells were incubated twice for 5 min each with 2 ml 0.05 M glycine-HCI, 0.15 M NaCI, pH 3.0, after the three rinses with binding buffer. The radioactivity in the combined acid washes was used to determine the surface-bound TNF alpha; the radioactivity in the subsequently solubilized (1% SDS) cells was used to determine the internalized TNF alpha. For quantitating the receptor content and affinity, cells grown to confluence in 6-well multi-well plates were rinsed once with Eagle's MEM containing 10% FCS (binding buffer), and then incubated at 4°C with 400,000 cpm of '25I-TNF alpha for 8 h in the presence of varying concentrations of unlabeled TNF alpha (25) . The medium was removed, the cells were rinsed three times with the binding buffer, and the cell-bound radioactivity was solubilized in 1% SDS and quantitated in a gamma counter. Nonspecific binding, determined in the presence of excess (100 nM) unlabeled TNF alpha, was subtracted from total binding to calculate specific binding. Scatchard (0, 3, 5, 7, or 10 d) in culture, its effect on DNA content was found to vary according to the time it was added to the cells (Fig. 2) . Addition of TNF alpha at the time of plating reduced plating efficiency by 13% (45 vs. 58% plating efficiency in TNF-treated and control cells, respectively). Addition of TNF alpha 24 h or more after plating had no effect on cell attachment as determined by the absence of cells in the medium at subsequent time points. Addition of TNF alpha to keratinocytes before confluence (day 6) inhibited the proliferation of these cells to a greater extent than addition of TNF alpha to cells after they had reached confluence. For example, cultures exposed to TNF alpha from day 3 or 5 had 37-45% reduction in DNA content at day 12 compared with controls, whereas cultures exposed to TNF alpha from day 7 or 10 had only a 3-20% reduction. Thus, the earlier and longer the cells are exposed to TNF alpha, the more profound the effect of TNF alpha on cell growth.
In clonal growth assays (Fig. 3) , doses > 0.1 nM TNF alpha significantly reduced the number of colonies in a dose-dependent fashion. 0.3 nM TNF alpha reduced the number of cells by 50% and concentrations > 1.0 nM reduced the cell numbers by > 80%. The growth inhibitory effect of TNF alpha observed in clonal growth assays was more pronounced than the inhibitory effect of TNF alpha in reducing the DNA con-* Figure 2 . Effect of TNF alpha on keratinocyte proliferation at different stages of growth. 30 tent as seen in Fig. 1 . This may be due to the lower seeding density of the clonal assay compared with the other experiments (clonal assays had 1/10 number of cells plated). To determine whether these antiproliferative effects of TNF alpha on keratinocytes were reversible we carried out the experiment described in Fig. 4 . Removal of TNF alpha from the medium after 5 d permitted the TNF alpha-exposed keratinocytes to achieve the same cell numbers as controls. (13, 27) although TNF alpha may actually promote growth in other cell lines (13) . Metabolic effects of TNF alpha in nontransformed cell lines include inhibition of lipoprotein lipase activity in 3T3-LI adipocytes and C2 myotubules (14) , inhibition of lipid uptake and synthesis and stimulation of FFA release in 3T3-LI adipocytes (18) , regulation of immune functions including induction of class I MHC antigens (15) , induction of tissue procoagulant activity in endothelial cells (16) , and induction of bone resorption and osteoclast formation in bone cell cultures (17) . The number of TNF alpha receptors reported for these cells varies from 200 to 9,000, with affinities ranging from 1 to 30 X 10-10 M (13, 14, (27) (28) (29) (30) (31) (32) (33) . In general the affinity of the TNF alpha receptor is appropriate for the potency ofthe biologic response in these cells, although not all cells with TNF alpha receptors have a detectable biologic response to TNF alpha (at least in terms ofcell lysis) (13) . As reported in our study, the keratinocyte receptor for TNF alpha is similar in affinity and number to other cell lines, but the response of the keratinocyte to TNF alpha in terms of differentiation (i.e., cornified envelope formation) is unique.
TNF alpha, in conjunction with other cytokines produced by fibroblasts and keratinocytes such as IL-1, may play a regulatory role in dermal-epidermal interactions during wound healing, inflammation, and epidermal growth and differentiation. It is not known whether TNF alpha is synthesized in keratinocytes, but it is conceivable that during inflammation or injury TNF alpha along with other cytokines such as IL-1 and IFN gamma are released into the circulation and accumulate in the skin. IFN, epidermal growth factor, and transforming growth factor beta are all known to effect proliferation and differentiation of keratinocytes (4-6); receptors for these cytokines have been demonstrated in keratinocytes (34) (35) (36) . The observations that TNF alpha regulates keratinocyte growth and differentiation and that TNF alpha accumulates in the skin after in vivo administration suggest that TNF alpha has a physiologic role in intact epidermis.
